arrow
H

Hidenori Shiraha

Okayama University
H指数:33
被引数:3,685

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Response to the letter: Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab

对字母的回应: 使用阿特珠单抗联合贝伐单抗在HCC中过渡到转换治疗的预测因素

2024-05-080
PRE
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab

使用阿特珠单抗联合贝伐单抗治疗肝细胞癌向转化治疗过渡的预测因素

2024-03-156
OAAI
Abnormal fucosylation of alpha-fetoprotein in patients with nonalcoholic steatohepatitis
2021-03-193
PREAI
High expression of a vascular stricture-related marker is predictive of an early response to tolvaptan, and a low fractional excretion of sodium is predictive of a poor long-term survival after tolvaptan administration for liver cirrhosis
2020-12-094
PREAI
Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib
2018-12-107
OAAI
Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma
2017-09-2613
PREAI
SUBCLINICAL PULMONARY HYPERTENSION IS A STRONG RISK OF POST LIVING DONOR LIVER TRANSPLANTATION SURVIVAL FOR LIVER CIRRHOSIS
2017-04-010
PREAI
Application of radiofrequency ablation for the treatment of intermediate-stage hepatocellular carcinoma

射频消融在中晚期肝癌治疗中的应用

2017-03-2024
PREAI